Abstract
This short tutorial review highlights the advance in high temperature solution phase chemical synthesis of monodisperse magnetic nanoparticles (MNPs), especially iron oxide NPs, as contrast enhancement agents for cancer detection by magnetic resonance imaging (MRI). It introduces briefly the unique nanomagnetism of MNPs required for MRI. It then summarizes some typical methods used to prepare monodisperse Fe3O4 and ferrite MFe2O4 MNPs from high temperature organic phase reaction with controlled magnetic properties. It further outlines the chemistry used to make these MNPs biocompatible and target-specific. Finally it presents two examples to demonstrate the MNP control achieved from chemical synthesis for sensitive detection of cancer.
Similar content being viewed by others
References
D.G. Mitchell, MRI Principles (W. B. Saunders Company, Philadelphia, PA, 1999)
M.O. Leach, C. Boggis, A. Dixon, D. Easton, R. Eeles, D. Evans, F. Gilbert, I. Griebsch, R. Hoff, P. Kessar, Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365, 1769–1778 (2005)
J.R. McCarthy, R. Weissleder, Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev. 60, 1241–1251 (2008)
L.M. Lacroix, D. Ho, S.H. Sun, Magnetic nanoparticles as both imaging probes and therapeutic agents. Curr. Top. Med. Chem. 10, 1184–1197 (2010)
J. Gallo, N.J. Long, E.O. Aboagye, Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. Chem. Soc. Rev. 42, 7816–7833 (2013)
J.-H. Lee, J.-W. Kim, J. Cheon, Magnetic nanoparticles for multi-imaging and drug delivery. Mol. Cells 35, 274–284 (2013)
B.D. Cullity, Introduction to Magnetic Materials (Addison Wesley Publishing Company, Reading, MA, 1972)
K M. Unruh, C.L. Chien in Nanomaterials: Synthesis, Properties and Applications Ch. 14, Ed. by A.S. Edelstein, R.C. Cammarata (Institute of Physics Publishing, Bristol, UK, 1996)
P. Caravan, Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 35, 512–523 (2006)
E.J. Werner, A. Datta, C.J. Jocher, K.N. Raymond, High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew. Chem. Int. Ed. 47, 8568–8580 (2008)
S.H. Koenig, K.E. Kellar, Theory of 1/T−1 and 1/T−2 Nmrd profiles of solutions of magnetic nanoparticles. Magn. Reson. Med. 34, 227–233 (1995)
Q.A. Pankhurst, J. Connolly, S.K. Jones, J. Dobson, Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 36, R167–R181 (2003)
C.B. Murray, C.R. Kagan, M.G. Bawendi, Synthesis and characterization of monodisperse nanocrystals and close-packed nanocrystal assemblies. Ann. Rev. Mater. Sci. 30, 545–610 (2000)
J.H. Lee, Y.M. Huh, Y. Jun, J. Seo, J. Jang, H.T. Song, S. Kim, E.J. Cho, H.G. Yoon, J.S. Suh, J. Cheon, Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13, 95–99 (2007)
J.W. Bulte, D.L. Kraitchman, Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484–499 (2004)
Y.-X.J. Wang, Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant. Imaging Med. Surgery 1, 35–40 (2011)
D. Haddad, M.F. Hildenbrand, K.H. Hiller, M. Haddad-Weber, P.M. Jakob, Specific identification of iron oxide-labeled stem cells using magnetic field hyperthermia and MR thermometry. NMR Biomed. 25, 402–409 (2012)
S.H. Sun, H. Zeng, Size-controlled synthesis of magnetite nanoparticies. J. Am. Chem. Soc. 124, 8204–8205 (2002)
S.H. Sun, H. Zeng, D.B. Robinson, S. Raoux, P.M. Rice, S.X. Wang, G.X. Li, Monodisperse MFe2O4 (M = Fe, Co., Mn) nanoparticles. J. Am. Chem. Soc. 126, 273–279 (2004)
J. Park, K.J. An, Y.S. Hwang, J.G. Park, H.J. Noh, J.Y. Kim, J.H. Park, N.M. Hwang, T. Hyeon, Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 3, 891–895 (2004)
J. Park, E. Lee, N.M. Hwang, M.S. Kang, S.C. Kim, Y. Hwang, J.G. Park, H.J. Noh, J.Y. Kini, J.H. Park, T. Hyeon, One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles. Angew. Chem. Int. Ed. 44, 2872–2877 (2005)
C. Barcena, A.K. Sra, G.S. Chaubey, C. Khemtong, J.P. Liu, J. Gao, Zinc ferrite nanoparticles as MRI contrast agents. Chem. Commun. 2224–2226 (2008). doi:10.1039/B801041B
J.T. Jang, H. Nah, J.H. Lee, S.H. Moon, M.G. Kim, J. Cheon, Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew. Chem. Int. Ed. 48, 1234–1238 (2009)
C. Xu, S. Sun, New forms of superparamagnetic nanoparticles for biomedical applications. Adv. Drug Deliver. Rev. 65, 732–743 (2013)
T. Borase, T. Ninjbadgar, A. Kapetanakis, S. Roche, R. O’Connor, C. Kerskens, A. Heise, D.F. Brougham, Stable aqueous dispersions of glycopeptide-grafted selectably functionalized magnetic nanoparticles. Angew. Chem. Int. Ed. 52, 3164–3167 (2013)
R.C. Ladner, Antibodies cut down to size. Nat. Biotechnol. 25, 875–877 (2007)
M.M. Goldenberg, Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin. Ther. 21, 309–318 (1999)
R.O. Dillman, Perceptions of Herceptin®: a monoclonal antibody for the treatment of breast cancer. Cancer Biother. Ratiopharm. 14, 5–10 (1999)
A.A. Jungbluth, E. Stockert, H.S. Huang, V.P. Collins, K. Coplan, K. Iversen, D. Kolb, T.J. Johns, A.M. Scott, W.J. Gullick, A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc. Natl. Acad. Sci. 100, 639–644 (2003)
L.P. Stabile, J.S. Lyker, C.T. Gubish, W. Zhang, J.R. Grandis, J.M. Siegfried, Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non–small cell lung cancer shows enhanced antiproliferative effects. Cancer Res. 65, 1459–1470 (2005)
W. Pao, J. Chmielecki, Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat. Rev. Cancer 10, 760–774 (2010)
E. Ruoslahti, M.D. Pierschbacher, New perspectives in cell adhesion: RGD and integrins. Science 238, 491–497 (1987)
E. Ruoslahti, RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12, 697–715 (1996)
R. Pasqualini, E. Koivunen, E. Ruoslahti, αv integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15, 542–546 (1997)
W. Arap, R. Pasqualini, E. Ruoslahti, Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377–380 (1998)
J. Xie, K. Chen, H.-Y. Lee, C. Xu, A.R. Hsu, S. Peng, X. Chen, S. Sun, Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin αVβ3-rich tumor cells. J. Am. Chem. Soc. 130, 7542–7543 (2008)
D. Ho, X. Sun, S. Sun, Monodisperse magnetic nanoparticles for theranostic applications. Acc. Chem. Res. 44, 875–882 (2011)
Acknowledgments
The work at Brown University was supported in part by NIH/NCI 1R21CA12859 and the Brown Imaging Fund.
Author information
Authors and Affiliations
Corresponding author
Additional information
This tutorial review is dedicated to Professor Dwight A. Sweigart for his long time mentorship and friendship.
Rights and permissions
About this article
Cite this article
Sun, S. Chemical Synthesis of Monodisperse Magnetic Nanoparticles for Sensitive Cancer Detection. J Inorg Organomet Polym 24, 33–38 (2014). https://doi.org/10.1007/s10904-013-9975-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10904-013-9975-x